IL-6 Inhibitor for UC Shows Some Promise in Mid-Stage Trial

(MedPage Today) -- Induction therapy with a novel interleukin 6 (IL-6) inhibitor for active ulcerative colitis yielded significantly higher rates of clinical response, remission, and mucosal healing than placebo, findings from a phase II study...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news